UNSPSC 51151547: Pilocarpine nitrate

This classification denotes a cholinergic agonist with the molecular formula C11H16N2O2.HNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M20T465H6J, chemically known as 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, (3s-cis)-, mononitrate but more generally known as pilocarpine nitrate, which bears US NIH Compound Identifier 83930. European Medicines Agency schedules Pilocarpine nitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03821MIG.

UNSPSC 51151547 Pilocarpine nitrate is a Commodity code that represents pharmaceutical products, though the recent state and local opportunities tagged under it do not match its nominal scope. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026, seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—emergency response and harm-reduction products entirely unrelated to pilocarpine nitrate, an ophthalmic agent used to treat glaucoma. The Texas Health and Human Services Commission's concurrent Request for Information HHS0017013 (posted April 3, 2026) solicits vendor capabilities for direct-to-manufacturer prescription programs serving state pharmacy benefit plans, a procurement-strategy tool rather than a product buy. Neither opportunity reflects actual demand for the coded product. The code shows minimal relevant recent activity; the opportunities appearing under it suggest either mislabeling in the source data or that the code is not actively used for state and local pharmaceutical procurement at present.

The two posted opportunities span different issuing bodies—a county health department and a state health agency—and different geographies (Florida and Texas), but they do not establish a pattern of demand for pilocarpine nitrate itself. Seminole County's naloxone buy requires quarterly deliveries with vendor-covered shipping, two-year initial term with one-year renewal option, E-Verify compliance, and drug-free workplace certification. The Texas HHS RFI is exploratory, seeking vendor input on direct contracting models outside traditional pharmacy benefit manager arrangements before formal procurement design. Neither provides a foothold for pursuing this code as written.